Rozanolixizumab (Anti-FcRn (FCGRT & B2M))

Synonyms: UCB7665

Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) is a high-affinity humanized monoclonal antibody, targeting human neonatal Fc receptor (FcRn) and is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases. MW: 150 KD.

Rozanolixizumab (Anti-FcRn (FCGRT & B2M))

Purity & Quality Control

Batch: A250001 Purity: 99% Protein concentration: 4.06mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) is a high-affinity humanized monoclonal antibody, targeting human neonatal Fc receptor (FcRn) and is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases. MW: 150 KD.

Product Details

CAS No. 1584645-37-3
Molecular Weight 150 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) | Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) supplier | purchase Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) | Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) cost | Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) manufacturer | order Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) | Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) distributor